Testing effectiveness (Phase 2)Study completedNCT00425854
What this trial is testing
An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer
Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 50